ROBERT W. KARR

Profile

First Name

: ROBERT

Middle Name

: W.

Last Name

: KARR

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

TERPENOID THERAPEUTICS, INC.

STEVEN COLLINS, MARK J DRISH, MARK J. DRISH, RAYMOND J HOHL, RAYMOND J. HOHL, JEFFREY D. NEIGHBORS, CURT NELSON, DAVID F WEIMER, DAVID WIEMER, DAVID F. WIEMER

EXECUTIVE OFFICER, DIRECTOR

EUCLISES PHARMACEUTICALS, INC.

ROBERT A. BEARDSLEY, CHARLES BOLTEN, CHARLES A. BOLTEN, ROBERT J. CALCATERRA, RAJESH DEVRAJ, EDUARDO J. MARTINEZ, RICK RYAN, BOBBY W. SANDAGE, JR., JOHN J. TALLEY, RANDY H. WEISS

EXECUTIVE OFFICER, DIRECTOR

KALTHLEEN L. BECKMANN, KATHLEEN L. BECKMANN, CHARLES BOLTEN, DAN BRODERICK, GEORGE CAPPS, JILL CARROLL, JOHN DONOVAN, WILLIAM FRAZIER, PAMELA MANNING, PAMELA T. MANNING, JOHN MCKEARN, PETER MOLDT, CAROLE L. NUECHTERLEIN, BOBBY W. SANDAGE, JR., JAMES STUTZ

EXECUTIVE OFFICER, DIRECTOR

ANTEGRIN THERAPEUTICS, INC.

BEN AUSPITZ, PETER BARRETT, CHARLES BOLTEN, GEORGE H. CAPPS II, GEORGE H. CAPPS, II, THOMAS P. CIRRITO, RAJESH DEVRAJ, DAVID W. GRIGGS, SCOTT SEIWERT, BRADFORD WILLIAMSON, MICHAEL YEADON, MICHAEL A. YEADON

EXECUTIVE OFFICER, DIRECTOR

TIOMA THERAPEUTICS, INC.

KALTHLEEN L. BECKMANN, KATHLEEN L. BECKMANN, CHARLES BOLTEN, DAN BRODERICK, GEORGE CAPPS, JILL CARROLL, JOHN DONOVAN, WILLIAM FRAZIER, PAMELA MANNING, PAMELA T. MANNING, JOHN MCKEARN, PETER MOLDT, CAROLE L. NUECHTERLEIN, BOBBY W. SANDAGE, JR., JAMES STUTZ

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2015-06-25

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2014-12-31

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2015-09-17

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2013-12-30

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2015-06-25

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity, Debt

2014-12-18

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2013-12-30

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2012-05-04

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2009-12-30